Pfizer goes back to court on Viagra ruling; PwC says drugmakers must start value selling;

@FiercePharma: Whistleblower lawsuit on Pfizer's Lipitor dismissed. Story | Follow @FiercePharma

> Pfizer ($PFE) has asked the Canada Supreme Court to reconsider its decision to invalidate its patent for Viagra there. Story 

> A new study from consultant PricewaterhouseCoopers suggests that drug companies will succeed better by pitching the value of their drugs to payers rather than just the benefits of their drugs for patients. Story

> A group of congressional Democrats have asked the GAO to investigate if there is a connection between drug shortages in the U.S. and a move toward use of larger compounding pharmacies like the one implicated in the recent meningitis outbreak. Release

> Cumberland Pharmaceuticals has turned on the FDA with a lawsuit over the agency's decision to allow InnoPharma to make a generic version of Cumberland's overdose treatment. Item

> India biotech company Biocon says it has an agreement giving Bristol-Myers Squibb ($BMY) the option to license globally Biocon's oral insulin drug program. Story

Biotech News

 @FierceBiotech: Novartis grabs EU committee support for first meningitis B vaccine. Article | Follow @FierceBiotech

 @JohnCFierce: Somehow doubt that Biocon really wanted an option deal for IN-105, its oral insulin program. More | Follow @JohnCFierce

 @RyanMFierce: Dynavax stock in pre-market meltdown mode after adcomm on hep B vax didn't back safety. More | Follow @RyanMFierce

> Bristol-Myers Squibb grabs option to Biocon's oral insulin amid diabetes growth. News

> Biotech outfit Geron nears spinoff of stem cell business. Story

Medical Device News

 @FierceMedDev: Cyberonics, a maker of neuromodulation devices, had a great Fy2013 Q2. Story | Follow @FierceMedDev

 @MarkHFierce: Thermo Fisher unveiled a new manufacturing facility in China. Item | Follow @MarkHFierce

 @DamianFierce: As advocates fight to repeal the device tax, we take a detailed look at how the 2.3% charge would work. Special Report | Follow @DamianFierce

> Cook nabs FDA approval for drug-eluting stent to treat PAD. News

> Dx startup Quanterix draws major bioMérieux investment. Article

> 'Fiscal cliff' overshadows push for device tax repeal. Story

And Finally... Sanofi ($SNY) has recruited "Weeds" actress Elizabeth Perkins, who has Type 1 diabetes, to be the face of its diabetes awareness campaign. Story

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.